Overview

Orthopedic Veterinary Implants Market to value over CAGR of over 9% from 2022 to 2028.

Orthopedic Veterinary Implants Market is speculated to grow positively during the forecast period. Lack of regulation and FDA approvals thus make the market relatively less governed and booming with opportunities and potential. This has encouraged regional players to foray into the market with new innovations. The swift uptake of less expensive substitutes in the global orthopedic veterinary implants market has had a positive impact on the market.

The rise in the number of pet owners with increasing disposable income is expected to have a direct positive boding on the global orthopedic veterinary implants market. Arthritis is prevalent in dogs and often the treatment involves orthopedic veterinary implants. The rising cases of obesity in pets owing to a sedentary lifestyle and overeating also favours the market’s growth. 

North America accounts for major market share in the global orthopedic veterinary implants. In the near future, the Asia Pacific orthopedic veterinary implants are predicted to grow at the highest CAGR.

Major market drivers in the orthopedic veterinary implants market are:

KYON Pharma, Inc., Veterinary Orthopedic Implants, Inc., Everost Inc., Integra LifeSciences, and BioMedtrix, LLC, Johnson & Johnson,B. Braun Melsungen AG, Orthomed (UK) Ltd, IMEX Veterinary, Securos Surgical.

Orthopedic Veterinary Implants Market Segmentation:

By Product Type 

• Total Knee Replacement (TKR) 
  o Cemented Total Knee Replacement 
  o Cementless Total Knee Replacement 
• Total Hip Replacement (THR) 
  o Cemented Total Hip Replacement 
  o Cementless Total Hip Replacement 
• Trauma Fixations 
  o External Fixations 
  o Internal Fixations 
     o Intramedullary (IM) Nails 
     o Bone Plates 
     o Bone Screws 
• Tibial Tuberosity Advancement (TTA) Implants 
• Tibial Plateau Leveling Osteotomy (TPLO) Implants 
• Advanced Locking Plate System (ALPS) 
• Total Elbow Replacement (TER) 

By End-User 
•    Veterinary Hospitals 
•    Veterinary Clinics

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape: 
•    Tier 1 players- established companies in the market with a major market share 
•    Tier 2 players
•    Emerging players which are growing rapidly
•    New Entrants  

FutureWise Takeaways: 
•    Growth prospects 
•    SWOT analysis
•    Key trends
•    Key data points affecting market growth 

Objectives of the Study:
•    To provide an exhaustive analysis on the global orthopedic veterinary implants market by product type, by end-user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East.
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

Flexible Delivery Model:
•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
    2.1. Research Data 
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation 
    2.3. Market Breakdown and Data Triangulation 
    2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Orthopedic Veterinary Implants Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Type Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Orthopedic Veterinary Implants Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Orthopedic Veterinary Implants Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Type Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Type Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Orthopedic Veterinary Implants Market, By Product Type Historical Analysis and Forecast 2020-2029(USD Million)
         7.1. Total Knee Replacement (TKR) 
                 7.1.1. Cemented Total Knee Replacement 
                 7.1.2. Cementless Total Knee Replacement 
         7.2. Total Hip Replacement (THR) 
                 7.2.1. Cemented Total Hip Replacement 
                 7.2.2. Cementless Total Hip Replacement 
         7.3. Trauma Fixations 
                 7.3.1. External Fixations 
                 7.3.2. Internal Fixations 
                            7.3.2.1. Intramedullary (IM) Nails 
                            7.3.2.2. Bone Plates 
                            7.3.2.3. Bone Screws 
         7.4. Tibial Tuberosity Advancement (TTA) Implants 
         7.5. Tibial Plateau Leveling Osteotomy (TPLO) Implants 
         7.6. Advanced Locking Plate System (ALPS) 
         7.7. Total Elbow Replacement (TER) 

8. Global Orthopedic Veterinary Implants Market, By End User Historical Analysis and Forecast 2020-2029(USD Million)
         8.1. Veterinary Hospitals
         8.2. Veterinary Clinics

9. North America Orthopedic Veterinary Implants Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        9.2.1. U.S.A
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Orthopedic Veterinary Implants Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. Brazil
          10.2.2. Venezuela
          10.2.3. Argentina
          10.2.4. Rest of Latin America
    10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Orthopedic Veterinary Implants Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Germany
          11.2.2. U.K         
          11.2.3. France
          11.2.4. Italy
          11.2.5. Spain
          11.2.6. Russia
          11.2.7. Poland
          11.2.8. Rest of Europe
    11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific Orthopedic Veterinary Implants Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Japan
          12.2.2. China
          12.2.3. India
          12.2.4. Australia and New Zealand
          12.2.5. ASEAN
          12.2.6. Rest of Asia Pacific
    12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. GCC
          13.2.2. Israel
          13.2.3. South Africa
          13.2.4. Rest of MEA
    13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
         15.1. KYON Pharma, Inc.
                   15.1.1. Company Overview
                   15.1.2. Product Portfolio
                   15.1.3. SWOT Analysis
                   15.1.4. Financial Overview
                   15.1.5. Strategic Overview
         15.2. Veterinary Orthopedic Implants, Inc.
                   15.2.1. Company Overview
                   15.2.2. Product Portfolio
                   15.2.3. SWOT Analysis
                   15.2.4. Financial Overview
                   15.2.5. Strategic Overview
         15.3. Everost Inc.
                   15.3.1. Company Overview
                   15.3.2. Product Portfolio
                   15.3.3. SWOT Analysis
                   15.3.4. Financial Overview
                   15.3.5. Strategic Overview
         15.4. Integra LifeSciences
                   15.4.1. Company Overview
                   15.4.2. Product Portfolio
                   15.4.3. SWOT Analysis
                   15.4.4. Financial Overview
                   15.4.5. Strategic Overview
         15.5. BioMedtrix, LLC
                   15.5.1. Company Overview
                   15.5.2. Product Portfolio
                   15.5.3. SWOT Analysis
                   15.5.4. Financial Overview
                   15.5.5. Strategic Overview
         15.6. Johnson & Johnson
                   15.6.1. Company Overview
                   15.6.2. Product Portfolio
                   15.6.3. SWOT Analysis
                   15.6.4. Financial Overview
                   15.6.5. Strategic Overview
         15.7. B. Braun Melsungen AG
                   15.7.1. Company Overview
                   15.7.2. Product Portfolio
                   15.7.3. SWOT Analysis
                   15.7.4. Financial Overview
                   15.7.5. Strategic Overview
         15.8. Orthomed (UK) Ltd
                   15.8.1. Company Overview
                   15.8.2. Product Portfolio
                   15.8.3. SWOT Analysis
                   15.8.4. Financial Overview
                   15.8.5. Strategic Overview
         15.9. IMEX Veterinary
                   15.9.1. Company Overview
                   15.9.2. Product Portfolio
                   15.9.3. SWOT Analysis
                   15.9.4. Financial Overview
                   15.9.5. Strategic Overview
         15.10. Securos Surgical
                   15.10.1. Company Overview
                   15.10.2. Product Portfolio
                   15.10.3. SWOT Analysis
                   15.10.4. Financial Overview
                   15.10.5. Strategic Overview

16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures